Phoenix Biotech, founded in 1992, is a leading company in the biotechnology and health care industries. The company's slogan "Advanced diagnostic solutions for accurate infectious disease detection" reflects its core focus. Phoenix Bio-Tech Corp specializes in medical diagnostic products and technical services, including both manual and custom automation of diagnostic systems.
One of the standout products offered by Phoenix Biotech is the TREP-SURE EIA, a recombinant-based ELISA product for the infectious diseases sector. It is designed for in vitro diagnostic detection of treponema pallidum antibodies in human serum or plasma with EDTA and citrate. Additionally, the company provides the TREP-CHEK Test Kit, a confirmatory in vitro enzyme immunoassay aimed at the qualitative detection of treponema pallidum IgG antibodies in human serum or plasma.
Despite the impressive track record of Phoenix Biotech and the potential of their diagnostic solutions, specific details about their headquarters, last investment, and related investors are not available at the moment. Nevertheless, Phoenix Biotech's commitment to advanced diagnostic solutions positions them as a potential contender in the biotechnology and health care sectors.
